Our mission
The SRI NA team engages in flexible partnering models that include early-stage seed-funding, sponsored research agreements and larger strategic partnerships across the drug discovery and development value chain. We are proud to help partners quickly advance novel discoveries into transformative medicines that benefit patients.

Bring Sanofi R&D and external experts together
Our Initiatives
We are committed to building value-generating partnerships across North America through two core initiatives to accelerate the R&D pipeline: Innovation Awards and larger Strategic Partnerships.
Innovation Awards
SRI leads two seed-funding initiatives that facilitate collaborations and new ways of thinking to develop the latest groundbreaking science and technologies that can both enrich and accelerate the R&D pipeline: The Innovation Awards (iAwards) and Innovations in Data Exploration, Analytics & Technology (iDEA-iTECH) awards. Award recipients benefit from access to R&D expertise and drug development capabilities to help advance their ideas over one year while also forging long-lasting partnerships.
Strategic Partnerships
SRI works hand in hand with the North American ecosystem to build strategic partnerships and accelerate innovation in R&D.

Stanford Immunology Research Partnership
In May 2021, Sanofi and Stanford University School of Medicine started a 3-year open innovation partnership to gain deeper insights into mechanisms underlying inflammatory diseases and advance innovative, translational concepts through the drug discovery pipeline.
Our team

Karen Chandross
PhD Head of Scientific Relations & Initiatives

Wayne Rowe
PhD iAwards Program Lead

Luke Hanlin
PhD iAwards Program Manager

Lucie Rochard
PhD External Engagement Program Lead

MaryClare McCorry
PhD Project Lead

Laura Chambre
PhD Project Lead

Jamee Downes
MA Coordinator, Scientific Relations & Initiatives